[Side effects and safety in drug therapy of hypertension].
Institute for Adult Diseases, Asahi Life Foundation.
K
K
Imataka
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D004232:Diuretics / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012110:Reserpine / Q000009:adverse effects; D012449:Safety
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004232:Diuretics; D012110:Reserpine